Clinical trials for Tumor of hematopoietic and lymphoid tissues
62 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT07249346Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell TransplantationHannah Choe, MD · PI: Hannah Choe, MD
- RECRUITINGPhase 1NCT06904066Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic MalignanciesNational Cancer Institute (NCI) · PI: James N Kochenderfer, M.D.
- RECRUITINGPhase 1NCT07270770BY002 IIT Study in R/R Acute LeukemiaThe First Affiliated Hospital of Soochow University · PI: Suning Chen, MD, PhD
- RECRUITINGPhase 1NCT07257419CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and LymphomaSt. Jude Children's Research Hospital · PI: Swati Naik, MBBS
- RECRUITINGPHASE1, PHASE2NCT07249905Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of LymphomaModeX Therapeutics, An OPKO Health Company
- RECRUITINGPHASE1, PHASE2NCT07471789Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).Gyala Therapeutics
- RECRUITINGN/ANCT07051525Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and FeverPeter MacCallum Cancer Centre, Australia · PI: Abby P Douglas, MBBS PhD FRACP
- RECRUITINGPhase 1NCT06441331Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive TumorsITM Solucin GmbH · PI: Roman Henkel, PhD
- RECRUITINGN/ANCT07390071Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell ImmunotherapyUniversity of Utah · PI: Douglas Sborov, MD, MS
- ACTIVE NOT RECRUITINGPhase 2NCT07162181Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood CancersEli Lilly and Company · PI: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
- RECRUITINGPhase 2NCT07101497Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute LeukemiaThe First Affiliated Hospital of Soochow University · PI: Su-ning Chen, M.D.
- RECRUITINGN/ANCT06803745Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · PI: Jonathan Webster
- RECRUITINGN/ANCT07300735Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood CancersAlexandria University · PI: Mai Moustafa Helmy, Professor
- RECRUITINGPhase 1NCT06575296Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell TransplantCity of Hope Medical Center · PI: Brian Ball, MD
- RECRUITINGN/ANCT06689800Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular TherapyWashington University School of Medicine · PI: Ginny Schulz, Ph.D., RN, CPNP-PC
- RECRUITINGPHASE1, PHASE2NCT06911710The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic TumorsTianjin Medical University General Hospital
- RECRUITINGPHASE1, PHASE2NCT06207123A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)University of Chicago
- RECRUITINGNCT06537726Breath Analysis for the Detection of Invasive Fungal InfectionsUniversity of Zurich · PI: Jeremy Deuel, PD Dr.
- RECRUITINGPhase 1NCT06501196A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic SyndromeBlossomHill Therapeutics · PI: Sponsor Contact
- RECRUITINGPhase 2NCT06229912A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX GenesM.D. Anderson Cancer Center · PI: Ghayas Issa, MD
- RECRUITINGNCT06058858Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study AnalysisAssistance Publique - Hôpitaux de Paris
- RECRUITINGN/ANCT06326268Interest of Light Therapy in Hematology - The PHOTO-TREAT StudyInstitut de cancérologie Strasbourg Europe · PI: Anne ZILLIOX, MD
- RECRUITINGPhase 1NCT06462365Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)Tr1X, Inc. · PI: Maria Grazia Roncarolo, MD
- RECRUITINGPhase 1NCT05887167Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological MalignanciesJoshua Sasine, MD, PhD · PI: Joshua Sasine, MD, PhD
- RECRUITINGN/ANCT06360718Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.Children's Hospital Los Angeles · PI: Erin Shields, MA
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06052813A Study of BN104 in the Treatment of Acute LeukemiaInstitut de Recherches Internationales Servier (I.R.I.S.) · PI: Depei WU, Prof.
- RECRUITINGPhase 1NCT05010564Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)Baylor College of Medicine · PI: Bahey Salem, MD
- RECRUITINGN/ANCT06353698Fasting Mimicking Diet With Chemotherapy in Patients With LeukemiaNational Nutrition and Food Technology Institute · PI: Ehsan Hejazi, PhD
- RECRUITINGNCT05702502Assessing the Presence of CT-DNA in Lymphoma Associated HLHNottingham University Hospitals NHS Trust
- RECRUITINGN/ANCT07403630INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)Azienda Ospedaliero-Universitaria di Parma
- ENROLLING BY INVITATIONNCT05600933Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor MicroenvironmentNational Cancer Institute (NCI) · PI: Steven A Rosenberg, M.D.
- RECRUITINGPhase 2NCT05800366A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell LymphomaJennifer Crombie, MD · PI: Jennifer Crombie, MD
- ACTIVE NOT RECRUITINGPhase 2NCT05673785A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)Takeda · PI: Study Director
- RECRUITINGPHASE1, PHASE2NCT05673057Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic SyndromeMolecular Partners AG
- RECRUITINGPHASE1, PHASE2NCT05751798Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or LymphomasOSE Immunotherapeutics
- RECRUITINGPhase 1NCT05476770Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic MalignanciesTherapeutic Advances in Childhood Leukemia Consortium · PI: Adam Lamble, MD
- ACTIVE NOT RECRUITINGPhase 1NCT05320809Study of 3D189 in Patients With Hematologic Malignancies3D Medicines · PI: jianxiang wang, Ph.D
- RECRUITINGPhase 1NCT05362773A Study of MGD024 in Patients With Relapsed or Refractory Hematologic MalignanciesMacroGenics · PI: Denise Casey, M.D.
- RECRUITINGNCT05046444Solving Riddles Through SequencingMunich Leukemia Laboratory
- RECRUITINGN/ANCT05108298Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN TrialsEastern Cooperative Oncology Group · PI: John M Salsman, PhD
- ACTIVE NOT RECRUITINGPhase 1NCT05024045Study of Oral LOXO-338 in Patients With Advanced Blood CancersEli Lilly and Company · PI: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
- ACTIVE NOT RECRUITINGN/ANCT04706676Integrative Neuromuscular Training in Adolescents and Children Treated for CancerRigshospitalet, Denmark · PI: Hanne B. Larsen, As. Prof
- ACTIVE NOT RECRUITINGEarly Phase 1NCT04514029Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-CelMasonic Cancer Center, University of Minnesota · PI: Joseph Maakaron, MD
- RECRUITINGNCT05011045Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic MalignanciesM.D. Anderson Cancer Center · PI: Bouthaina S Dabaja
- RECRUITINGNCT04466059Better Leukemia Diagnostics Through AI (BELUGA)Munich Leukemia Laboratory · PI: Wolfgang Kern, Prof. Dr.
- RECRUITINGNCT03555851Factors Affecting Post-transplant Cyclophosphamide (PTCy) EfficacyWake Forest University Health Sciences · PI: Aleksander Chojecki, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03413800Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell TransplantCiusss de L'Est de l'Île de Montréal · PI: Jean Roy, MD
- ACTIVE NOT RECRUITINGPhase 1NCT03459170Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo TransplantBellicum Pharmaceuticals · PI: Bellicum Pharmaceuticals
- RECRUITINGNCT02677064Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute LeukemiaMemorial Sloan Kettering Cancer Center · PI: Roni Tamari, MD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT02542657Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple MyelomaJoseph Tuscano · PI: Joseph Tuscano
- ENROLLING BY INVITATIONNCT02473757Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell StudiesNational Cancer Institute (NCI) · PI: James N Kochenderfer, M.D.
- ACTIVE NOT RECRUITINGPhase 2NCT02323867Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic MalignanciesChildren's Hospital of Philadelphia · PI: Timothy Olson, MD, PhD
- RECRUITINGNCT02595255AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)Erasme University Hospital · PI: Isabelle Demeestere, PhD
- RECRUITINGNCT02134574Prospective Cohort With Hemopathy in Languedoc-RoussillonUniversity Hospital, Montpellier · PI: GUILLAUME CARTRON
- RECRUITINGEarly Phase 1NCT02356653Expanded Access Protocol Using CD3+/CD19+ Depleted PBSCChildren's Hospital of Philadelphia · PI: Timothy Olson, MD, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT01415752Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell LymphomaEastern Cooperative Oncology Group · PI: Mitchell R. Smith, MD, PhD
- ACTIVE NOT RECRUITINGNCT01199562Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantCity of Hope Medical Center · PI: Ryotaro Nakamura
- RECRUITINGNCT01137825Registry of Older Patients With CancerUNC Lineberger Comprehensive Cancer Center · PI: Hyman Muss, MD
- RECRUITINGNCT01137643Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerUNC Lineberger Comprehensive Cancer Center · PI: Paul Armistead, MD
- ACTIVE NOT RECRUITINGPhase 1NCT00368082Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)Baylor College of Medicine · PI: Helen E Heslop, MD
- RECRUITINGNCT00582621Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative DisordersMemorial Sloan Kettering Cancer Center · PI: Kenneth Offit, MD
- ACTIVE NOT RECRUITINGPhase 3NCT00002462RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's DiseaseEuropean Organisation for Research and Treatment of Cancer - EORTC · PI: John Raemaekers, MD, PhD